Wellington Shields & Co’s Bristol-Myers Squibb BMY Stock Holding History

Wellington Shields & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.44M	Sell	40,174 -366	-0.9%	-$21.3K	0.62%	40
2025 Q4	$2.19M	Buy	40,540 +638	+2%	+$30.7K	0.54%	44
2025 Q3	$1.8M	Hold	39,902	–	–	0.47%	49
2025 Q2	$1.85M	Sell	39,902 -432	-1%	-$21.2K	0.52%	45
2025 Q1	$2.46M	Buy	40,334 +1,080	+3%	+$63K	0.77%	26
2024 Q4	$2.22M	Buy	39,254 +3,428	+10%	+$192K	0.68%	32
2024 Q3	$1.85M	Sell	35,826 -153	-0.4%	-$7.18K	0.56%	37
2024 Q2	$1.49M	Buy	35,979 +746	+2%	+$33.4K	0.49%	46
2024 Q1	$1.91M	Sell	35,233 -1,750	-5%	-$89.1K	0.64%	33
2023 Q4	$1.9M	Buy	36,983 +504	+1%	+$26.5K	0.7%	31
2023 Q3	$2.12M	Buy	36,479 +14	+0%	+$858	0.53%	29
2023 Q2	$2.33M	Sell	36,465 -1,500	-4%	-$101K	0.55%	23
2023 Q1	$2.63M	Buy	37,965 +300	+0.8%	+$21.2K	0.59%	23
2022 Q4	$2.71M	Buy	37,665 +425	+1%	+$32K	0.62%	20
2022 Q3	$2.65M	Buy	37,240 +25	+0.1%	+$1.81K	1.15%	22
2022 Q2	$2.87M	Sell	37,215 -8,000	-18%	-$609K	0.69%	22
2022 Q1	$3.3M	Buy	45,215 +1,500	+3%	+$101K	1.09%	21
2021 Q4	$2.73M	Sell	43,715 -5,510	-11%	-$323K	0.54%	25
2021 Q3	$2.91M	Buy	49,225 +1,510	+3%	+$99.4K	1.02%	22
2021 Q2	$3.19M	Sell	47,715 -1,100	-2%	-$71.7K	1.05%	20
2021 Q1	$3.08M	Sell	48,815 -2,600	-5%	-$162K	1.1%	20
2020 Q4	$3.19M	Sell	51,415 -700	-1%	-$43K	1.14%	18
2020 Q3	$3.14M	Buy	52,115 +500	+1%	+$30.1K	1.32%	16
2020 Q2	$3.04M	Buy	51,615 +415	+0.8%	+$24.8K	1.33%	17
2020 Q1	$2.85M	Sell	51,200 -610	-1%	-$37.3K	1.57%	12
2019 Q4	$3.33M	Buy	+51,810	New	+$2.97M	1.47%	15
2019 Q3	–	Sell	-43,350	Closed	-$1.97M	–	106
2019 Q2	$1.97M	Sell	43,350 -200	-0.5%	-$9.32K	0.93%	26
2019 Q1	$2.08M	Sell	43,550 -4,050	-9%	-$202K	1.06%	24
2018 Q4	$2.47M	Buy	47,600 +3,550	+8%	+$191K	1.42%	17
2018 Q3	$2.73M	Sell	44,050 -200	-0.5%	-$11.9K	1.48%	18
2018 Q2	$2.45M	Sell	44,250 -600	-1%	-$32.4K	1.27%	23
2018 Q1	$2.84M	Buy	44,850 +100	+0.2%	+$6.43K	1.53%	18
2017 Q4	$2.74M	Sell	44,750 -1,754	-4%	-$110K	1.47%	18
2017 Q3	$2.96M	Buy	46,504 +1,200	+3%	+$70.1K	0.98%	14
2017 Q2	$2.52M	Buy	45,304 +1,300	+3%	+$70.7K	0.87%	19
2017 Q1	$2.39M	Sell	44,004 -3,324	-7%	-$182K	0.72%	20
2016 Q4	$2.77M	Sell	47,328 -3,041	-6%	-$166K	1.45%	16
2016 Q3	$2.72M	Sell	50,369 -890	-2%	-$57.2K	1.38%	15
2016 Q2	$3.77M	Sell	51,259 -89	-0.2%	-$6.29K	2.34%	10
2016 Q1	$3.28M	Sell	51,348 -988	-2%	-$62.3K	2.19%	10
2015 Q4	$3.6M	Buy	52,336 +270	+0.5%	+$17.8K	2.39%	8
2015 Q3	$3.08M	Sell	52,066 -5,799	-10%	-$368K	2.33%	8
2015 Q2	$3.85M	Sell	57,865 -743	-1%	-$49K	1.28%	7
2015 Q1	$3.78M	Buy	58,608 +7	+0%	+$438	2.23%	6
2014 Q4	$3.46M	Buy	58,601 +3,557	+6%	+$201K	1.97%	7
2014 Q3	$2.82M	Sell	55,044 -1,596	-3%	-$79.7K	1.77%	11
2014 Q2	$2.75M	Buy	56,640 +704	+1%	+$34.7K	1.72%	11
2014 Q1	$2.91M	Buy	55,936 +4	+0%	+$213	1.83%	12
2013 Q4	$2.97M	Buy	55,932 +3	+0%	+$153	2.01%	10
2013 Q3	$2.59M	Buy	55,929 +54	+0.1%	+$2.37K	2.05%	10
2013 Q2	$2.5K	Buy	+55,875	New	+$2.43M	0.08%	11

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Shields & Co's BMY Position: Q1 2026 in Review

Wellington Shields & Co reduced its Bristol-Myers Squibb (BMY) stake by 0.9% in Q1 2026, selling an estimated $21.3K and leaving 40,174 shares worth $2.44M. The position accounts for 0.62% of the portfolio, ranked #40.

Wellington Shields & Co first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.85M in Q2 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Wellington Shields & Co held 40,174 shares of Bristol-Myers Squibb worth $2.44M as of Q1 2026.
Wellington Shields & Co sold 366 Bristol-Myers Squibb shares in Q1 2026, an estimated $21.3K.
Bristol-Myers Squibb made up 0.62% of Wellington Shields & Co's portfolio in Q1 2026, its #40 holding.
Wellington Shields & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
Wellington Shields & Co's Bristol-Myers Squibb position peaked at $3.85M in Q2 2015.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.